Mirae Asset Global Investments Co. Ltd. Reduces Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Mirae Asset Global Investments Co. Ltd. reduced its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 5.9% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 14,916 shares of the company’s stock after selling 938 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Henry Schein were worth $1,024,000 as of its most recent filing with the SEC.

Other hedge funds have also modified their holdings of the company. Farther Finance Advisors LLC raised its holdings in shares of Henry Schein by 237.3% during the 1st quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company’s stock valued at $186,000 after buying an additional 1,898 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in Henry Schein by 1.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,191,677 shares of the company’s stock worth $82,464,000 after purchasing an additional 16,616 shares during the last quarter. Oppenheimer Asset Management Inc. increased its holdings in Henry Schein by 5.2% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 13,745 shares of the company’s stock worth $941,000 after purchasing an additional 678 shares during the last quarter. State of Alaska Department of Revenue increased its holdings in Henry Schein by 2.8% during the 1st quarter. State of Alaska Department of Revenue now owns 14,611 shares of the company’s stock worth $1,000,000 after purchasing an additional 395 shares during the last quarter. Finally, GAMMA Investing LLC increased its holdings in Henry Schein by 37.8% during the 1st quarter. GAMMA Investing LLC now owns 3,939 shares of the company’s stock worth $270,000 after purchasing an additional 1,081 shares during the last quarter. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on HSIC shares. Piper Sandler dropped their price objective on Henry Schein from $83.00 to $77.00 and set an “overweight” rating on the stock in a report on Wednesday, April 30th. Wells Fargo & Company dropped their price objective on Henry Schein from $80.00 to $75.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 6th. Wall Street Zen downgraded Henry Schein from a “buy” rating to a “hold” rating in a report on Thursday, April 17th. Finally, Barrington Research dropped their price objective on Henry Schein from $90.00 to $86.00 and set an “outperform” rating on the stock in a report on Tuesday, May 6th. Six research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $79.30.

Henry Schein Price Performance

Shares of HSIC opened at $74.67 on Friday. The firm has a market cap of $9.09 billion, a price-to-earnings ratio of 23.33, a PEG ratio of 2.41 and a beta of 0.87. The stock has a 50 day moving average of $70.70 and a 200-day moving average of $71.18. The company has a current ratio of 1.38, a quick ratio of 0.75 and a debt-to-equity ratio of 0.50. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping the consensus estimate of $1.11 by $0.04. The company had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 14.87% and a net margin of 3.21%. The business’s revenue was down .1% on a year-over-year basis. During the same quarter last year, the firm earned $1.10 EPS. As a group, analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.